Whittier Street Health Center to Honor Vertex Pharmaceuticals Executive Chairman Jeffrey Leiden at Its 2024 Annual Gala

Whittier’s Annual Roast to Toast Fundraiser on April 3rd, 2024 Will Support Health and Social Services for Boston’s Most Vulnerable Residents

BOSTON, MA / ACCESSWIRE / March 11, 2024 / Whittier’s 2024 “Toast of Jeffrey Leiden” will continue the health center’s long tradition of shining a light on Boston’s standout business leaders and philanthropists while raising critical funds to provide high-quality medical care and social services to patients regardless of their ability to pay for services.

Caricature of Dr. Jeffrey Leiden
Toast of Jeffrey Leiden

WCVB Channel 5 “CityLine” host and executive producer Karen Holmes Ward will emcee the event, which will feature live entertainment by Anima. Members of the public are invited to attend.

When: Wednesday, April 3, 2024, 5:30-9:00 p.m.
Where: Hilton Boston Park Plaza Hotel, 50 Park Plaza, Boston, MA 02116
Click here to purchase a ticket: https://www.wshc.org/event/toast-of-jeffrey-leiden-m-d-ph-d-executive-chairman-vertex/

Speakers include John Fish, Chairman & CEO, Suffolk Construction, Joe Nolan, Chairman, President & CEO, Eversource Energy, Dr. Reshma Kewalramani, President, Vertex Pharmaceuticals, Dr. Betsy Nabel and Dr. Gary Nabel of ModeX Therapeutics, Dr. Joan Reede, Dean of for Diversity and Community Partnerships, Harvard Medical School, Paul Burton, Journalist, Channel 4 (Boston), Former Congressman Joe Kennedy, and Dr. Sangeeta N. Bhatia, Koch Institute for Integrative Cancer Research.

“Dr. Leiden has been a staunch supporter of Whittier and is one of our most caring and passionate health equity champions,” said Frederica M. Williams, Whittier Street Health Center’s president and CEO. “He understands and cares deeply about the serious health and social inequities that exist in Boston.”

“We’re excited to celebrate Jeff as a compassionate scientist, physician and corporate leader who has a long record as a relentless champion for health equity. And we thank Vertex Pharmaceuticals and our event sponsors for strengthening Whittier’s ability to ensure greater access to high-quality and culturally sensitive health care and social services by implementing innovative programs and services that promote better health and well-being to the residents of Roxbury, the South End, Dorchester, Mattapan, Jamaica Plain and surrounding neighborhoods,” Williams said.

Dr. Leiden currently serves as Executive Chairman of Vertex Pharmaceuticals and was the Chief Executive Officer and President from 2012 through to March 2020. During his tenure as CEO, Dr. Leiden established a signature program at Vertex to enhance STEAM education among students in Vertex’s local communities, including an on-site Learning Lab, mentorship programs, internships and college scholarships.

Contact Information

Press Office
Media and Communications Office
info@wshc.org
617-989-3221

President’s Office
President & CEO
events@wshc.org
617-989-3221

SOURCE: Whittier Street Health Center

View the original press release on newswire.com.

Staff

Recent Posts

HealthTech Market Size to Reach $3,140.9 Billion by 2033 Globally, at 13.1% CAGR: Allied Market Research

The global healthtech market is experiencing rapid growth due to increasing health awareness and preventive…

2 hours ago

myTomorrows and Scout Clinical Partner to Provide Cross-Border Patient Recruitment for Clinical Trials

This innovative tech collaboration addresses emotional, logistical and financial challenges associated with international clinical trial…

2 hours ago

Astraveus Strengthens Leadership Team and Board

Jean-Paul Mangeolle joins as Chairman of the Board of DirectorsDavid Newble appointed as an Independent Board MemberLaurence…

2 hours ago

NEC Laboratories Europe and Data-Driven.AI enhance AI medical diagnosis to improve the early detection of disease and illness

HEIDELBERG, Germany, April 15, 2025 /PRNewswire/ -- NEC Laboratories Europe and Data-Driven.AI are working together to…

2 hours ago

Open nominations for the BIAL Award in Biomedicine 2025 with an increased amount to €350,000

Created to distinguish the most remarkable scientific discoveries in the biomedical field, this international award has…

2 hours ago

WELL Health Announces Results for Q4 and Full Year 2024 Reflecting Record Annual Revenue

WELL achieved annual revenue of $919.7 million in 2024, an increase of 19% compared to…

2 hours ago